Aviso Financial Inc. Sells 1,758 Shares of Humana Inc. (NYSE:HUM)

Aviso Financial Inc. cut its position in Humana Inc. (NYSE:HUM - Free Report) by 86.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 284 shares of the insurance provider's stock after selling 1,758 shares during the quarter. Aviso Financial Inc.'s holdings in Humana were worth $72,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp raised its position in shares of Humana by 1.0% in the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider's stock valued at $1,701,582,000 after buying an additional 53,272 shares in the last quarter. Pzena Investment Management LLC increased its position in Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after purchasing an additional 1,103,132 shares in the last quarter. FMR LLC increased its position in Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock worth $1,073,387,000 after purchasing an additional 643,291 shares in the last quarter. Ontario Teachers Pension Plan Board increased its position in Humana by 6.5% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock worth $371,705,000 after purchasing an additional 71,910 shares in the last quarter. Finally, Sanders Capital LLC increased its position in Humana by 1.0% during the 3rd quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider's stock worth $370,060,000 after purchasing an additional 11,923 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

A number of equities analysts recently issued reports on HUM shares. StockNews.com cut shares of Humana from a "buy" rating to a "hold" rating in a research report on Tuesday. Morgan Stanley lowered their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Barclays upped their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research report on Thursday, February 13th. Piper Sandler boosted their target price on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $285.68.

Humana Stock Down 1.0 %

Shares of HUM stock traded down $2.77 on Wednesday, hitting $267.01. The stock had a trading volume of 1,614,192 shares, compared to its average volume of 1,714,713. The business has a 50 day moving average of $271.45 and a 200 day moving average of $278.29. The stock has a market cap of $32.23 billion, a price-to-earnings ratio of 26.84, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio is currently 35.58%.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.37% of the stock is currently owned by insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.